Pilot Feasibility Grant
The Diabetes Research Center funds Pilot Feasibility projects related to diabetes for up to $50,000 per year. Projects are generally funded for a year, but can be extended for a second year, based on progress. The Pilot Feasibility Program solicits applications from qualified investigators, ensures prompt peer-review, oversees grant administration, monitors funded investigators records of productivity, and integrates sponsored research with other programmatic enrichment activities. Investigators need not be Diabetes Research Center members at the time of application. However, they need to be appointed to the faculty. Please note that graduate students and postdoctoral fellows are NOT eligible to apply. Three types of applications are considered: Proposals from young investigators who have not held any prior funding to carry out preliminary studies leading to an NIH, ADA, or JDFR grant application Proposals for innovative and high-risk projects by established investigators in the field of diabetes Proposals from established investigators, without prior funding in diabetes, who wish to undertake a diabetes project Applicants may request up to $50,000 per year for up to two years. Indirect costs are NOT applicable. A second year of funding will be based on demonstrated progress and availability of funds. The awards can be used for salary support and research expenses. Proposals will be reviewed by two outside experts. Continue reading >>
- A Website to Promote Physical Activity in People With Type 2 Diabetes Living in Remote or Rural Locations: Feasibility Pilot Randomized Controlled Trial
- Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
- Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study
About The Diabetes Research Institute Foundation
The Diabetes Research Institute Foundation (DRIF) is the organization of choice for those who are serious, passionate, and committed to curing diabetes. Its mission - to provide the Diabetes Research Institute with the funding necessary to cure diabetes now - is a testament to the belief that tomorrow is not soon enough to cure those living with diabetes. The Diabetes Research Institute has become the world leader it is today through the substantial funding provided by the DRI Foundation. Supported by private philanthropy, the DRIF ensures the jumpstarting of new ideas and the continuation of innovative research projects that remain cure-focused and will ultimately benefit those with diabetes. The DRI Foundation is recognized as one of the world's most respected diabetes organizations. Garnering the attention of influential people who are personally affected by diabetes, the Foundation has grown into an international coalition of business leaders, celebrities, scientists, clinicians, families and other concerned individuals who have elevated the importance of cure-focused research and provided meaningful support for the DRI's multidisciplinary research program. This funding is provided through individual and corporate donations , special events , sponsorships, cause marketing relationships, and planned giving , which allows donors to provide a gift in the form of a will, trust, or other deferred giving vehicle. A 501(c)(3) not-for-profit corporation, the DRI Foundation has thousands of supporters in the United States and worldwide, and, in addition to its headquarters in Florida, operates regional development offices in New York and Washington, D.C. The Diabetes Research Institute Foundation was created for one reason - to cure diabetes- which is and will continue to b Continue reading >>
Welcome | Efsd
Applicants to all EFSD programmes must be paid-up members of EASD. Access MyEASD to apply for EASD membership or to manage your account. For further information, please see here or contact [email protected] . Applicants toEFSD collaborative programmeswith non-European countries are exempt from this regulation. Information for potential grant applicants EFSD continuously strives to offer funding streams that are well suited to todays research needs and that attract the very best grant applications to move the field forward. This brochureis designed to encourage you to apply for funding and to help you put together the best possible application:we hope you will find it interesting and helpful! Simply click on the document on the left to start reading and watching or download here and save to your device to capture the embedded videos. The European Association for the Study of Diabetes e.V. (EASD) is a non-profit, medical scientific association and was founded in 1965. The aims of the Association are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application. more Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. more Register now for the 54th EASD Annual Meeting! #EASD2018 will be full of exciting insights into the most recent research findings in all aspects of #diabetology. #EASD2018 #diabetes #research #T1D #T2D #Berlin - pic.twitter.com/fq0LTCK3G6 Continue reading >>
Apply For A Grant
Welcome to Novo Nordisk in the United States Sponsorships: Sponsorship support is given to organizations for activities that have a positive impact on Novo Nordisk therapeutic areas of interest and have demonstrated the ability to work toward initiatives that benefit the health care profession and patient communities. Independent Education Grants Eligibility: Grant submissions will be accepted from different types of medical education providers, such as health care organizations, associations, academic institutions, medical education and communication companies, and hospitals. We encourage collaboration with nonprofit organizations that participate in patient care or represent those involved in patient care with established high-quality standards. Charitable Gifts: To be considered, requests must be from 501(c)(3) organizations located in the communities where our employees live and work. Preference will be given to proposals that address health and wellness. The Novo Nordisk Grants Management System allows you to register and submit an application for funding for HCP Educational Grants, Community and Patient Health Education, Charitable Giving and Sponsorships requests. The site is restricted to the submission of HCP Educational Grants, Community and Patient Health Education, Charitable Giving and/or Sponsorships requests only. Continue reading >>
Research Grants, Awards & Competitions
Research > Research Grants, Awards & Competitions Diabetes Canada is proud to be a leading supporter of diabetes research in Canada. Since 1975 and the establishment of the Charles H. Best Research Fund, Diabetes Canada has funded thousands of Canadas most renowned scientists, scholars, and clinicians in their quest for new and innovative developments in the prevention, treatment, and management of diabetes. Each year, the National Research Council (NRC) of Diabetes Canadabased on the recommendations of our five peer review committeesmakes final funding decisions for both Operating Grant and Personnel Award applications. We are collaborating to advance the management of diabetes in Canada. Sara has lived with diabetes since she was ten and in 2016, her worst nightmare came true: her daughter Sophie was diagnosed with diabetes. This meant endless needles, blood sugar checks and constant worry. More than anything, Sara wants to End Diabetes so that Sophie can live to see a cure. Alone, we wont accomplish much. But together, we could give Sophie and millions of others a cure. Your support today can help fund a cure and END DIABETES NOW. Continue reading >>
Apply For A Diabetes Uk Research Grant
We offer a wide range of funding opportunities - you can read more about each funding scheme in this section. You can refer to our general guidelines for more information on how to apply. You can also contact us for information and advice, at [email protected] . It is mandatory that all applications are submitted through the online grants application portal. Read our research grants management system user guide for information on how to submit an application through the online portal and our tips on writing a research grant application to help you write your application. If you have any questions about the online portal please contact the Research Team at [email protected] Please note: You must allow enough time to complete the approval process - all signatories must have approved your application before the specified funding round deadline. Harry Keen Intermediate Clinical Fellowship To allow outstanding medically qualified professionals, and other clinically qualified professionals to establish themselves as independent researchers, with a view to a long-term career as a clinical research leader in the field of diabetes. This includes nurses, pharmacists and members of the Allied Health Professions, who have gained a PhD or equivalent (e.g. MD (Res). Sir George Alberti Research Training Fellowship To enable graduates currently working in the NHS to study for a PhD or MD in diabetes research and develop a career in research. Applications are invited from individuals working in a patient-facing role including, but not limited to, doctors, nurses, midwives, psychologists and dietitians. It is our intention for this scheme to be as inclusive as possible. IDia Innovators in Diabetes Training Programme IDia is a fully funded three-year training programme, op Continue reading >>
Funding Opportunities
The CDTR compiles and regularly updates a list of potential funding opportunities related to obesity, diabetes, and translational research. In addition, the Washington University Office of the Vice Chancellor of Research maintains a comprehensive database of both internal and external funding resources. By a.a.gambari on March 7, 2018 in Front Page , Funding Opportunities Precision Public Health Call for Proposals The Institute for Public Health is requesting proposal... By a.a.gambari on February 20, 2018 in Front Page , Funding Opportunities Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Re... By a.a.gambari on February 20, 2018 in Front Page , Funding Opportunities Incorporating Patient-Reported Outcomes into Clinical Care for Type 1Diabetes (R01 Clinical Tria... By allisonphad on January 31, 2018 in Front Page , Funding Opportunities Center for Dissemination & Implementation Pilot Grants The center will offer two funding prog... By allisonphad on November 27, 2017 in Funding Opportunities Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01 Clinical Trial ... By allisonphad on November 6, 2017 in Funding Opportunities R01: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) This Fundi... By allisonphad on November 1, 2017 in Funding Opportunities Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) The purpose... By allisonphad on October 16, 2017 in Funding Opportunities The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promi... By allisonphad on September 15, 2017 in Funding Opportunities Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R Continue reading >>
Diabetes Research & Wellness Foundation Amrc | Drwf
DRWF accepts research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. The maximum support of these grants is up to $50,000 per year for up to 2 years. If the proposed research is within an area of primary interest and is judged as having high scientific merit by the Foundations advisors, the Board of Directors may make special grant awards that exceed the stated maximum. Currently, the Foundations area of primary interest and focus are islet cell transplantation, macrovascular disease & neuropathy. All other research proposals will not be reviewed. Research proposals are evaluated along the following parameters: Qualifications and experience of the investigators Human subjects participating in research supported by DRWF must give their prior legally acceptable and informed consent. A blank copy of the consent form used should accompany the application. The care and treatment of human and animal subjects should be in compliance with NIH guidelines. A written progress report describing the accomplishments and or findings of the project is due 3 months after completion of the project or 1 year after the receipt of funds, whichever comes first. Publications and presentations resulting from research funded in whole or in part by DRWF shall contain this acknowledgment: "Supported by a grant from Diabetes Research and Wellness Foundation." A reprint of any article or publication carrying this acknowledgment shall be provided to DRWF. DRWF awards a limited number of program grants, the amount of which is based on available funds. The program must be educational or community health oriented, and targeted to people with diabetes or health professionals working in the field of diabetes. All proposals submitted to DRWF Continue reading >>
Michigan Diabetes Research Center: Funding Opportunities
NIDDK Program Projects (P01) (PAR-16-127) Description: This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research. Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Dates(s): Multiple dates, see announcement. High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) (PAR-16-126) Description: The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach encouraged by this FOA is envisioned to generate a community research resource for the broader community, which may include discovery-based or hypothesis-generating science. The interdisciplinary research team should be able to provide an integrative plan of working together to effectively address the complex challenge at hand. This program will support research projects that accelerate critical breakthroughs, early and applied research on cutting-edge technologies, and new approaches to improve the synergy and interactions among multi- and interdisciplinary research teams, including sharing of data and other resources to further advance research in this area. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods Continue reading >>
Special Diabetes Program: Funding Opportunities
Special Diabetes Program: Funding Opportunities Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required) Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (R01 Clinical Trial Required) Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for Type 1 Diabetes Therapy (R01 Clinical Trial Optional) The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional) Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed) Continue reading >>
Hjelt Foundations Research Grants
We congratulate the new Diabetes grant holders for 2018! Enming Zhang and Isabella Artner, Lund University Diabetes Centre LUDC. Karim Gariani and Cecilia Jimnez Snchez, University of Geneva. Read more The Bo & Kerstin Hjelt Foundation for type 2 diabetes research was established in 2008 and has as a long-term goal to fund research to prevent and cure type 2 diabetes. The Foundation finances diabetes research at the Medical Faculties of Lund University, Sweden and Geneva University, Switzerland. The foundation solicits applications from independent investigators or young scientists on the way to independence. Preference will be given to novel projects rather than support for on-going research. The subsidy can cover salaries and/or costs for consumables including laboratory rodents. Equipment and other infrastructure will not be financed. The application period for 2017 is 16 October 1 December. Project funding beginning on April 1st, 2018 After completion of your year as a grant holder, The Bo and Kerstin Hjelt Diabetes Foundation require a short summary of your project, focusing on the results and importance of the findings for Diabetes type II, at the end of the stipend-period. Project Report deadline: August 31. Continue reading >>
Diabetes Uk - Funding And Funding Opportunities
You are here: Home Funding organisations Diabetes UK Diabetes UK is a charity fundingresearch into the cause and prevention of diabetes as well as improving care and treatment. In 2014, the charity spent around 7m on research across a range of funding opportunities including research grants, fellowships and PhD studentships, as well as occasional calls for research in a specific area. The charity focuses on research with the potential to make a difference to the lives of people with diabetes, so funding applications are assessed not only on the basis of their scientific merit but also on this potential. provide support for diabetes research projects for up to five years. There is no limit to the level of support requested butapplicants applying for 500,000 or more must contact the Diabetes UK Research department in the first instance and should normally hold substantial funding from Diabetes UK or another funding body.Salaries may be requested for research (both postgraduate and postdoctoral) and technical assistants. Applicants must have a tenured post or be able to demonstrate that they will have a salary and position at the institution they are applying from for the lifetime of the grant. Two deadlines per year (June/Dec). support early-career researchers at key career transition points with the aim of enabling successful recipients to go on to secure further, more significant, funding. The scheme will now operate through two distinct funding streams, one for medically qualified scientists and one for basic scientists. Small grants are not intended to be used for top-up funds. Salary costs may be requested but should not make up the total amount of the award. One deadline per year. Applications from medically qualified applicants will now be considered through our p Continue reading >>
University Of Washington - Diabetes Research Center Funding Opportunities
The overall goal of the Funding Opportunities at the University of Washington Diabetes Research Center is to promote the development of new and innovative research projects directed at basic, clinical and translational aspects of diabetes. Using funds provided by NIDDK and additional funds provided by the University of Washington, the Program has the following specific objectives: To provide initial research support for junior faculty who have not yet had independent peer-reviewed NIH funding; To provide pilot funding for established faculty who are entering the field of diabetes research for the first time; To support pilot projects by established investigators that propose to pursue a new and novel direction in their diabetes research; and To foster training in research related to diabetes by offering postdoctoral and graduate fellowships for mentored research in the laboratories of Diabetes Research Center affiliate investigators. Research support provided by the Pilot and Feasibility Studies Program is primarily intended to be a first grant for junior faculty interested in diabetes research, who have not yet obtained a major peer-reviewed grant, such as from NIH or NSF. Senior faculty are also eligible to apply if their projects represent a first entry into the field of diabetes research. The Diabetes Research Center Pilot and FeasibilityAwards are funded by the NIH grant to the Diabetes Research Center (P30 DK017047) at a maximum of $50,000 per year for up to two years. The DRCis now accepting applications for the 2018 Pilot and Feasibility Awards. Click here for more information. The New Investigator Award is sponsored by the University of Washington and provides $25,000 per year for up to two years to a member of the University of Washington faculty making a fir Continue reading >>
Rural Health Funding By Topic: Diabetes
Summaries of funding programs are provided by RHIhub for your convenience. Please contact the funder directly for the most complete and current information. Grants for research projects to improve understanding of the causes and reduce/eliminate health disparities for diseases considered high priority by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), including diabetes, obesity, hepatitis C, and others. Geographic coverage: Nationwide and U.S. Territories Application Deadline: May 7, 2018 Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services Grants to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the healthcare system-level, as well as within clinical settings. Application Deadline: Apr 11, 2019 Sponsors: National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services Grants to support tribal practices that build resiliency and connections to community, family, and culture, which over time, can reduce risk factors for chronic disease among American Indians and Alaska Natives. Application Deadline: Feb 20, 2018 Sponsors: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Department of Health and Human Services Funding to support small-scale, evidenced-based or evidence-informed health outreach projects that contribute to the reduction of health disparities in Appalachian communities in Kentucky. Application Deadline: Feb 16, 2018 Continue reading >>
Research Funding Opportunities Stanford Diabetes Research Center
Administrative Supplements to Existing NIH Grants and Cooperative Agreements The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. JDRF Canadian Clinical Trial Network (CCTN) FY18 Postdoctoral Fellowship in Clinical Translation in T1D Program - March 27, 2018 JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce that Eli Lilly Canada Inc. has provided $120,000 in support of two CCTN Post-Doctoral Fellows for one year in the sum of $60,000 each. Restoring Pancreatic Alpha Cell Function to Improve Metabolic Control in Type 1 Diabetes - February 21, 2018 JDRF is committed to facilitating the discovery and translation of promising targets or therapeutics to improve and restore glycemic control in people with type 1 Diabetes (T1D). NIH Special Funding Program for Type 1 Diabetes: New Funding Opportunities The NIDDK is pleased to share with you a list of newly issued Funding Opportunity Announcements (FOAs) that are soliciting research applications relevant to type 1 diabetes and its complications: The Leona M. and Harry B. Helmsley Charitable Trust Type 1 Diabetes (T1D) Program: Future Technologies Initiative (FTI) - June 15, 2018 Helmsleys Type 1 Diabetes Program has launched a Request for Proposals the Future Technologies Initiative (FTI). The goal of the FTI is to incubate proof-of-concept, early-stage research and development in the Continue reading >>
